144 related articles for article (PubMed ID: 32051569)
1. Antimicrobial and antibiofilm activities of ursolic acid against carbapenem-resistant Klebsiella pneumoniae.
Qian W; Wang W; Zhang J; Wang T; Liu M; Yang M; Sun Z; Li X; Li Y
J Antibiot (Tokyo); 2020 Jun; 73(6):382-391. PubMed ID: 32051569
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of eugenol against carbapenem-resistant Klebsiella pneumoniae and its effect on biofilms.
Qian W; Sun Z; Wang T; Yang M; Liu M; Zhang J; Li Y
Microb Pathog; 2020 Feb; 139():103924. PubMed ID: 31837416
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial and antibiofilm activities of paeoniflorin against carbapenem-resistant Klebsiella pneumoniae.
Qian W; Zhang J; Wang W; Wang T; Liu M; Yang M; Sun Z; Li X; Li Y
J Appl Microbiol; 2020 Feb; 128(2):401-413. PubMed ID: 31602708
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Drug Resistance of Carbapenem-Resistant
Gao L; Lv Y; Li Y
Microb Drug Resist; 2020 Aug; 26(8):944-950. PubMed ID: 32043901
[No Abstract] [Full Text] [Related]
5. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro.
Zhang J; Yu L; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
Ann Palliat Med; 2019 Nov; 8(5):622-631. PubMed ID: 31735038
[TBL] [Abstract][Full Text] [Related]
6. Role of Coptis chinensis in antibiotic susceptibility of carbapenem-resistant Klebsiella pneumoniae.
Tseng CY; Sun MF; Kao TC; Li TC; Lin CT
J Microbiol Immunol Infect; 2022 Oct; 55(5):946-955. PubMed ID: 34332892
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial and Antibiofilm Activities and Mechanism of Action of Chelerythrine Against Carbapenem-Resistant
Qian WD; Huang J; Zhang JN; Li XC; Kong Y; Wang T; Li YD
Microb Drug Resist; 2021 Aug; 27(8):1105-1116. PubMed ID: 33439767
[No Abstract] [Full Text] [Related]
8. In-vitro antibacterial activity and mechanism of Monarda didyma essential oils against Carbapenem-resistant Klebsiella pneumoniae.
Chen Y; Zhao J; Liu C; Wu D; Wang X
BMC Microbiol; 2023 Sep; 23(1):263. PubMed ID: 37730531
[TBL] [Abstract][Full Text] [Related]
9. Komodo-dragon cathelicidin-inspired peptides are antibacterial against carbapenem-resistant
Hitt SJ; Bishop BM; van Hoek ML
J Med Microbiol; 2020 Nov; 69(11):1262-1272. PubMed ID: 33084564
[No Abstract] [Full Text] [Related]
10. Antimicrobial and Antibiofilm Activities of Citral Against Carbapenem-Resistant
Qian W; Liu M; Fu Y; Wang T; Zhang J; Yang M; Sun Z; Li X; Li Y
Foodborne Pathog Dis; 2020 Jul; 17(7):459-465. PubMed ID: 31985261
[TBL] [Abstract][Full Text] [Related]
11. Determining the susceptibility of carbapenem resistant Klebsiella pneumoniae and Escherichia coli strains against common disinfectants at a tertiary hospital in China.
Chen Y; Liao K; Huang Y; Guo P; Huang H; Wu Z; Liu M
BMC Infect Dis; 2020 Jan; 20(1):88. PubMed ID: 32000698
[TBL] [Abstract][Full Text] [Related]
12. A Study of the Virulence Traits of Carbapenem-Resistant
Khalil MAF; Hager R; Abd-El Reheem F; Mahmoud EE; Samir T; Moawad SS; Hefzy EM
Microb Drug Resist; 2019 Sep; 25(7):1063-1071. PubMed ID: 31033413
[TBL] [Abstract][Full Text] [Related]
13. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.
Gheitani L; Fazeli H; Moghim S; Nasr Isfahani B
Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):70-74. PubMed ID: 29412797
[TBL] [Abstract][Full Text] [Related]
14. Weak biofilm formation among carbapenem-resistant Klebsiella pneumoniae.
Cusumano JA; Caffrey AR; Daffinee KE; Luther MK; Lopes V; LaPlante KL
Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114877. PubMed ID: 31484626
[TBL] [Abstract][Full Text] [Related]
15. Role of efflux pumps inhibitor in decreasing antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital in North India.
Filgona J; Banerjee T; Anupurba S
J Infect Dev Ctries; 2015 Aug; 9(8):815-20. PubMed ID: 26322872
[TBL] [Abstract][Full Text] [Related]
16. Characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital in Fuzhou, China.
Chen D; Li H; Zhao Y; Qiu Y; Xiao L; He H; Zheng D; Li X; Huang L; Yu X; Xu N; Hu X; Chen Y; Chen F
J Appl Microbiol; 2020 Nov; 129(5):1220-1226. PubMed ID: 32396222
[TBL] [Abstract][Full Text] [Related]
17. Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant
Yu L; Zhang J; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
Front Cell Infect Microbiol; 2019; 9():422. PubMed ID: 31921701
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis.
Zhu WM; Yuan Z; Zhou HY
Antimicrob Resist Infect Control; 2020 Jan; 9(1):23. PubMed ID: 32005246
[TBL] [Abstract][Full Text] [Related]
19. Prospective investigation of carbapenem-resistant Klebsiella pneumonia transmission among the staff, environment and patients in five major intensive care units, Beijing.
Yan Z; Zhou Y; Du M; Bai Y; Liu B; Gong M; Song H; Tong Y; Liu Y
J Hosp Infect; 2019 Feb; 101(2):150-157. PubMed ID: 30529506
[TBL] [Abstract][Full Text] [Related]
20. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
